UNITED RESEARCH LABORATORIES/MUTUAL PHARMACEUTICAL COMPANY FORMALLY NOTIFIES ADAMS RESPIRATORY THERAPEUTICS OF ITS ANDA FILING FOR GUAIFENESIN EXTENDED-RELEASE TABLETS, 600 MG AND 1200 MG

United Research Laboratories, Inc. and Mutual Pharmaceutical Company, Inc. ("Mutual") announce that Mutual has notified Adams Respiratory Therapeutics that Mutual has filed an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration (FDA) for Mutual's guaifenesin extended-release tablets, 600 mg and 1200 mg, which are the generic equivalent to Adams' Mucinex brand.
Red Orbit